𝔖 Bobbio Scriptorium
✦   LIBER   ✦

905 A RETROSPECTIVE STUDY OF ENTECAVIR THERAPY IN CHRONIC SEVERE HEPATITIS B

✍ Scribed by J. Chen

Book ID
117377910
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
50 KB
Volume
50
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Severe lactic acidosis during treatment
Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function
✍ Christian M. Lange; JΓΆrg Bojunga; Wolf Peter Hofmann; Katrin Wunder; Ulrike Mihm πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 221 KB πŸ‘ 1 views

Entecavir is a potent nucleoside inhibitor of the hepatitis B virus (HBV) polymerase with a high antiviral efficacy and a high genetic barrier to viral resistance. After approval in 2006, knowledge on the side effect profile in patients with advanced liver disease and impaired liver function is stil

Early hepatitis B virus DNA reduction in
Early hepatitis B virus DNA reduction in hepatitis B e antigen–positive patients with chronic hepatitis B: A randomized international study of entecavir versus adefovir
✍ Nancy Leung; Cheng-Yuan Peng; Hie-Won Hann; Jose Sollano; Judy Lao-Tan; Chao-Wei πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 382 KB πŸ‘ 2 views

This study was undertaken to compare the early antiviral activity and viral kinetic profiles of entecavir (ETV) versus adefovir (ADV) in hepatitis B e antigen positive nucleoside-naΓ―ve adults with chronic hepatitis B (CHB). Sixty-nine nucleoside-naΓ―ve CHB patients with baseline HBV DNA of 10(8) copi